Balance Sheet Miura Co., Ltd.

Stocks

6005

JP3880800002

Industrial Machinery & Equipment

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-11 am EDT			5-day change	1st Jan Change
3,117.00 ^JPY	-0.10%		+0.55%	+2.57%

May. 14	Miura Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI
May. 14	Miura Co., Ltd. Proposes Cash Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 29, 2026; Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2027 and Fiscal Year Ending March 31, 2027	CI

eb80263120abc920980d96b05e.ebTZWGorIC7RGEVcwud3L9ssckb5b11erg-SjJVDPVg.DPjpayV9f1enW2hq7484XJBzFCLOJD5s_lbI5eUodCka_JEMOhgXYrwtJg

Published financial data: MIURA CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	135B	144B	158B	160B	251B
Total Revenues	135B	144B	158B	160B	251B
Cost of Goods Sold, Total	79.76B	84.56B	94.06B	92.87B	157B
Gross Profit	54.97B	58.99B	64.32B	66.83B	94.23B
Selling General & Admin Expenses, Total	30.57B	33.29B	35.53B	37.58B	54.61B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	3.16B	2.9B	3.35B	3.21B	4.56B
Depreciation & Amortization - (IS)	4.03B	4.04B	4.23B	3.97B	10.25B
Other Operating Expenses	-304M	-484M	-507M	-778M	-688M
Other Operating Expenses, Total	37.46B	39.74B	42.61B	43.98B	68.73B
Operating Income	17.52B	19.24B	21.71B	22.85B	25.5B
Interest Expense, Total	-71M	-68M	-84M	-80M	-1.6B
Interest And Investment Income	342M	407M	633M	930M	1.27B
Net Interest Expenses	271M	339M	549M	850M	-333M
Income (Loss) On Equity Invest.	-	439M	1.23B	2.8B	4.71B
Currency Exchange Gains (Loss)	-37M	267M	263M	261M	86M
Other Non Operating Income (Expenses)	456M	278M	132M	233M	220M
EBT, Excl. Unusual Items	18.21B	20.56B	23.88B	27B	30.18B
Gain (Loss) On Sale Of Investments	26M	-66M	-500M	-193M	-113M
Gain (Loss) On Sale Of Assets	-69M	-79M	86M	-20M	-126M
Asset Writedown	-	-	-4M	4M	-312M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	18.16B	20.42B	23.47B	26.79B	29.63B
Income Tax Expense	5.45B	6.02B	6.48B	7.32B	6.27B
Earnings From Continuing Operations	12.71B	14.4B	16.99B	19.47B	23.36B
Net Income to Company	12.71B	14.4B	16.99B	19.47B	23.36B
Minority Interest	-15M	13M	-110M	-99M	-51M
Net Income - (IS)	12.7B	14.42B	16.88B	19.37B	23.31B
Net Income to Common Incl Extra Items	12.7B	14.42B	16.88B	19.37B	23.31B
Net Income to Common Excl. Extra Items	12.7B	14.42B	16.88B	19.37B	23.31B
Per Share Items
Net EPS - Basic	112.62	127.73	149.52	175	206.35
Basic EPS - Continuing Operations	112.62	127.73	149.52	175	206.35
Basic Weighted Average Shares Outstanding	113M	113M	113M	111M	113M
Net EPS - Diluted	112.43	127.55	149.39	174.89	206.26
Diluted EPS - Continuing Operations	112.43	127.55	149.39	174.89	206.26
Diluted Weighted Average Shares Outstanding	113M	113M	113M	111M	113M
Normalized Basic EPS	100.81	114	131.28	151.56	166.51
Normalized Diluted EPS	100.64	113.84	131.16	151.46	166.44
Dividend Per Share	35	39	45	53	61
Payout Ratio	31.05	29.7	27.46	28.09	25.57
Supplemental Items
EBITDA	24.25B	26.12B	28.74B	29.56B	39.9B
EBITA	17.52B	19.24B	21.71B	22.85B	25.5B
EBIT	17.52B	19.24B	21.71B	22.85B	25.5B
EBITDAR	24.86B	26.73B	29.37B	30.16B	40.53B
Effective Tax Rate - (Ratio)	30.03	29.47	27.61	27.33	21.15
Normalized Net Income	11.36B	12.87B	14.82B	16.77B	18.81B
Non-Cash Pension Expense	383M	388M	409M	422M	934M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.9B	2.06B	2.29B	2.23B	2.66B
Research And Development Expense From Footnotes	3.16B	2.9B	3.35B	3.21B	4.56B
Net Rental Expense, Total	610M	605M	626M	602M	631M
Imputed Operating Lease Interest Expense	42.71M	37.91M	49.29M	55.62M	114M
Imputed Operating Lease Depreciation	567M	567M	577M	546M	517M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	37.43B	40.04B	30.56B	37.29B	55.25B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	37.43B	40.04B	30.56B	37.29B	55.25B
Accounts Receivable, Total	38.63B	42.68B	41.58B	47.93B	71.06B
Total Receivables	38.63B	42.68B	41.58B	47.93B	71.06B
Inventory	19.66B	23.44B	26.89B	30.09B	39.57B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	21.3B	18.77B	48.87B	22.87B	13.54B
Total Current Assets	117B	125B	148B	138B	179B
Net Property Plant And Equipment	48.85B	48.98B	46.2B	47.53B	70.48B
Long-term Investments	15.3B	28.95B	29.35B	49.8B	65.81B
Goodwill	6.04B	6.04B	-	-	40.42B
Other Intangibles, Total	7.47B	8.1B	4.08B	4.02B	80.46B
Deferred Tax Assets Long-Term	1.66B	2.16B	2.01B	1.44B	2.97B
Other Long-Term Assets, Total	5M	5M	4M	3M	5M
Total Assets	196B	219B	230B	241B	440B
Liabilities
Accounts Payable, Total	13.92B	15.92B	12.4B	14.26B	23.8B
Accrued Expenses, Total	4.81B	5.49B	5.25B	5.92B	8.39B
Short-term Borrowings	-	1.31B	450M	-	-
Current Portion of Long-Term Debt	350M	750M	491M	12M	8.29B
Current Portion of Leases	2.54B	2.6B	2.47B	2.6B	3.18B
Current Income Taxes Payable	9.59B	10.94B	8.92B	12.7B	12.38B
Other Current Liabilities	12.96B	14.8B	17.91B	19.06B	29.57B
Total Current Liabilities	44.16B	51.81B	47.88B	54.54B	85.61B
Long-Term Debt	-	562M	17M	4M	106B
Long-Term Leases	4.6B	4.66B	3.77B	4.04B	18.02B
Pension & Other Post Retirement Benefits	71M	76M	71M	135M	562M
Deferred Tax Liability Non Current	1.62B	1.44B	81M	99M	22.8B
Other Non Current Liabilities	394M	377M	8.83B	621M	615M
Total Liabilities	50.84B	58.92B	60.65B	59.45B	234B
Common Stock, Total	9.54B	9.54B	9.54B	9.54B	9.54B
Additional Paid In Capital	10.84B	12.39B	12.4B	12.44B	21.34B
Retained Earnings	129B	139B	151B	164B	181B
Treasury Stock	-6.91B	-6.7B	-10.79B	-16.69B	-10.65B
Comprehensive Income and Other	2.81B	5.82B	6.28B	11.47B	2.44B
Total Common Equity	145B	160B	168B	181B	204B
Minority Interest	51M	39M	564M	819M	1.57B
Total Equity	145B	160B	169B	182B	206B
Total Liabilities And Equity	196B	219B	230B	241B	440B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	113M	113M	112M	110M	116M
ECS Total Common Shares Outstanding	113M	113M	112M	110M	116M
Book Value / Share	1.29K	1.42K	1.5K	1.64K	1.76K
Tangible Book Value	132B	146B	164B	177B	83.27B
Tangible Book Value Per Share	1.17K	1.29K	1.47K	1.6K	719.74
Total Debt	7.49B	9.88B	7.19B	6.66B	136B
Net Debt	-29.94B	-30.17B	-23.37B	-30.63B	80.48B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-3.9B	-4.49B	-4.79B	-6.44B	-7.4B
Debt Equivalent Oper. Leases	4.88B	4.84B	5.01B	4.82B	5.05B
Minority Interest, Total (Incl. Fin. Div)	51M	39M	564M	819M	1.57B
Equity Method Investments, Total	-	14.61B	15.2B	33.63B	51.6B
Inventories - Raw Materials, Total	9.19B	11.13B	13.24B	15.34B	22.2B
Inventories - Work In Process, Total	4B	4.49B	4.4B	4.61B	5.5B
Inventories - Finished Goods, Total	6.48B	7.82B	9.25B	10.14B	11.87B
Inventories - Others	1M	1M	2M	1M	1M
Full Time Employees	6.05K	6.07K	6.14K	6.06K	7.73K
Accumulated Allowance for Doubtful Accounts (Supple)	75M	79M	70M	51M	491M
Order Backlog	4.6B	5.78B	7.28B	9.43B	46.3B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	18.16B	20.42B	23.47B	26.79B	29.63B
Depreciation & Amortization - CF	6.73B	6.88B	7.03B	6.71B	14.41B
Depreciation & Amortization, Total	6.73B	6.88B	7.03B	6.71B	14.41B
(Gain) Loss From Sale Of Asset	79M	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	1.05B	113M
(Income) Loss On Equity Investments - (CF)	-	-439M	-1.23B	-2.8B	-4.71B
Other Operating Activities, Total	-4.28B	-5.84B	-7.01B	-4.51B	-7.4B
Change In Accounts Receivable	4.46B	-3.4B	-2.24B	-5.53B	-2.94B
Change In Inventories	939M	-3B	-5.18B	-2B	5.48B
Change In Accounts Payable	-2.12B	2.62B	807M	1.33B	246M
Change in Other Net Operating Assets	-994M	2.19B	2.2B	-229M	-701M
Cash from Operations	22.98B	19.44B	17.84B	20.81B	34.12B
Capital Expenditure	-2.35B	-2.44B	-1.61B	-2.2B	-6.12B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-13.84B	-150M	-1.62B	-141B
Sale (Purchase) of Intangible assets	-1.16B	-1.91B	-1.05B	-767M	-714M
Investment in Marketable and Equity Securities, Total	-7.65B	3.7B	-5.75B	3.44B	12.94B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	89M	8M	-3.98B	-118M	176M
Cash from Investing	-11.07B	-14.48B	-12.54B	-1.27B	-135B
Short Term Debt Issued, Total	-	1.31B	-	-	-
Long-Term Debt Issued, Total	-	1.5B	-	-	126B
Total Debt Issued	-	2.81B	-	-	126B
Short Term Debt Repaid, Total	-505M	-	-877M	-450M	-
Long-Term Debt Repaid, Total	-500M	-537M	-939M	-491M	-11.48B
Total Debt Repaid	-1B	-537M	-1.82B	-941M	-11.48B
Issuance of Common Stock	-	1.7B	-	-	14.87B
Repurchase of Common Stock	-	-	-4.14B	-5.92B	-
Common Dividends Paid	-3.94B	-4.28B	-4.63B	-5.44B	-5.96B
Common & Preferred Stock Dividends Paid	-3.94B	-4.28B	-4.63B	-5.44B	-5.96B
Other Financing Activities, Total	-3.04B	-3.08B	-3.17B	-3.1B	-3.72B
Cash from Financing	-7.99B	-3.39B	-13.77B	-15.4B	120B
Foreign Exchange Rate Adjustments	682M	1.04B	467M	1.1B	-1.23B
Miscellaneous Cash Flow Adjustments	-1M	-	-1.48B	-1M	-
Net Change in Cash	4.6B	2.61B	-9.48B	5.24B	17.96B
Supplemental Items
Cash Interest Paid	72M	69M	84M	80M	1.6B
Cash Income Tax Paid (Refund)	4.21B	5.76B	7.9B	5.15B	8.75B
Levered Free Cash Flow	9.71B	15.08B	-17.23B	41.87B	21.43B
Unlevered Free Cash Flow	9.75B	15.12B	-17.18B	41.92B	22.43B
Change In Net Working Capital	4.41B	-572M	35.12B	-23.9B	1.07B
Net Debt Issued / Repaid	-1B	2.28B	-1.82B	-941M	115B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.71	5.79	6.05	6.07	4.68
Return on Total Capital	7.42	7.44	7.84	7.84	6.02
Return On Equity %	9.12	9.42	10.32	11.11	12.07
Return on Common Equity	9.11	9.43	10.27	11.1	12.12
Margin Analysis
Gross Profit Margin %	40.8	41.09	40.61	41.85	37.49
SG&A Margin	22.69	23.19	22.44	23.53	21.73
EBITDA Margin %	18	18.2	18.15	18.51	15.88
EBITA Margin %	13	13.4	13.71	14.31	10.14
EBIT Margin %	13	13.4	13.71	14.31	10.14
Income From Continuing Operations Margin %	9.43	10.03	10.72	12.19	9.3
Net Income Margin %	9.42	10.04	10.66	12.13	9.28
Net Avail. For Common Margin %	9.42	10.04	10.66	12.13	9.28
Normalized Net Income Margin	8.43	8.96	9.36	10.5	7.48
Levered Free Cash Flow Margin	7.21	10.51	-10.88	26.22	8.53
Unlevered Free Cash Flow Margin	7.24	10.54	-10.85	26.25	8.93
Asset Turnover
Asset Turnover	0.7	0.69	0.71	0.68	0.74
Fixed Assets Turnover	2.76	2.93	3.33	3.41	4.26
Receivables Turnover (Average Receivables)	3.31	3.53	3.76	3.57	4.22
Inventory Turnover (Average Inventory)	4.01	3.92	3.74	3.26	4.51
Short Term Liquidity
Current Ratio	2.65	2.41	3.09	2.53	2.1
Quick Ratio	1.72	1.6	1.51	1.56	1.48
Operating Cash Flow to Current Liabilities	0.52	0.38	0.37	0.38	0.4
Days Sales Outstanding (Average Receivables)	110.22	103.38	97.09	102.57	86.4
Days Outstanding Inventory (Average Inventory)	91.07	93.02	97.65	112.28	80.91
Average Days Payable Outstanding	68.62	61.64	52.99	50.78	41.7
Cash Conversion Cycle (Average Days)	132.67	134.76	141.75	164.07	125.62
Long Term Solvency
Total Debt/Equity	5.15	6.16	4.26	3.67	65.98
Total Debt / Total Capital	4.89	5.8	4.08	3.54	39.75
LT Debt/Equity	3.16	3.26	2.24	2.23	60.41
Long-Term Debt / Total Capital	3.01	3.07	2.15	2.15	36.39
Total Liabilities / Total Assets	25.9	26.88	26.42	24.67	53.2
EBIT / Interest Expense	246.72	282.97	258.45	285.64	15.88
EBITDA / Interest Expense	341.55	384.13	342.18	369.48	24.86
(EBITDA - Capex) / Interest Expense	308.42	348.18	323.01	341.91	21.04
Total Debt / EBITDA	0.31	0.38	0.25	0.23	3.4
Net Debt / EBITDA	-1.23	-1.15	-0.81	-1.04	2.02
Total Debt / (EBITDA - Capex)	0.34	0.42	0.27	0.24	4.02
Net Debt / (EBITDA - Capex)	-1.37	-1.27	-0.86	-1.12	2.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.2	6.54	10.33	0.83	57.39
Gross Profit, 1 Yr. Growth %	-4.16	7.3	9.04	3.9	41
EBITDA, 1 Yr. Growth %	-2.95	7.72	10.04	2.84	34.99
EBITA, 1 Yr. Growth %	-4.84	9.85	12.83	5.26	11.57
EBIT, 1 Yr. Growth %	-4.84	9.85	12.83	5.26	11.57
Earnings From Cont. Operations, 1 Yr. Growth %	-7.53	13.31	17.94	14.61	20.01
Net Income, 1 Yr. Growth %	-7.65	13.55	17.07	14.77	20.36
Normalized Net Income, 1 Yr. Growth %	-3.13	13.21	15.17	13.2	12.15
Diluted EPS Before Extra, 1 Yr. Growth %	-7.66	13.45	17.12	17.07	17.94
Accounts Receivable, 1 Yr. Growth %	-9.63	10.49	-2.59	15.3	48.25
Inventory, 1 Yr. Growth %	-2.34	19.18	14.74	11.88	31.53
Net Property, Plant and Equip., 1 Yr. Growth %	0.2	0.27	-5.67	2.87	48.3
Total Assets, 1 Yr. Growth %	4.86	11.62	4.75	4.97	82.42
Tangible Book Value, 1 Yr. Growth %	10.12	10.71	12.46	7.56	-52.87
Common Equity, 1 Yr. Growth %	9.14	10.14	5.09	7.33	12.98
Cash From Operations, 1 Yr. Growth %	26.83	-15.4	-8.22	16.62	63.95
Capital Expenditures, 1 Yr. Growth %	-35.91	3.95	-34.15	36.96	177.78
Levered Free Cash Flow, 1 Yr. Growth %	40.35	55.33	-214.26	-342.99	-48.82
Unlevered Free Cash Flow, 1 Yr. Growth %	39.88	55.05	-213.59	-344.02	-46.49
Dividend Per Share, 1 Yr. Growth %	-5.41	11.43	15.38	17.78	15.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.5	-0.04	8.42	5.48	25.98
Gross Profit, 2 Yr. CAGR %	0.42	1.41	8.17	6.44	21.04
EBITDA, 2 Yr. CAGR %	9.59	2.24	8.87	6.38	17.82
EBITA, 2 Yr. CAGR %	2.99	2.24	11.33	8.98	8.37
EBIT, 2 Yr. CAGR %	2.99	2.24	11.33	8.98	8.37
Earnings From Cont. Operations, 2 Yr. CAGR %	1.53	2.36	15.6	16.26	17.28
Net Income, 2 Yr. CAGR %	1.68	2.4	15.3	15.91	17.53
Normalized Net Income, 2 Yr. CAGR %	3.45	4.72	14.19	14.18	12.67
Diluted EPS Before Extra, 2 Yr. CAGR %	1.65	2.35	15.27	17.1	17.5
Accounts Receivable, 2 Yr. CAGR %	-3.49	-0.07	3.74	5.98	30.74
Inventory, 2 Yr. CAGR %	1.26	7.89	16.94	13.3	21.31
Net Property, Plant and Equip., 2 Yr. CAGR %	9.82	0.23	-2.75	-1.49	23.52
Total Assets, 2 Yr. CAGR %	6.18	8.19	8.13	4.86	38.38
Tangible Book Value, 2 Yr. CAGR %	8.82	10.41	11.58	9.98	-28.8
Common Equity, 2 Yr. CAGR %	7.76	9.64	7.58	6.21	10.12
Cash From Operations, 2 Yr. CAGR %	15.81	3.58	-11.88	3.46	38.28
Capital Expenditures, 2 Yr. CAGR %	-21.75	-18.38	-17.26	-5.03	95.05
Levered Free Cash Flow, 2 Yr. CAGR %	-12.78	47.65	33.22	66.62	11.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12.64	47.27	32.71	66.49	14.27
Dividend Per Share, 2 Yr. CAGR %	2.99	2.67	13.39	16.58	16.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.56	1.11	3.31	5.83	20.53
Gross Profit, 3 Yr. CAGR %	3.95	2.67	3.89	6.72	16.9
EBITDA, 3 Yr. CAGR %	11.78	8.96	4.78	6.82	15.17
EBITA, 3 Yr. CAGR %	8.51	5.23	5.65	9.27	9.83
EBIT, 3 Yr. CAGR %	8.51	5.23	5.65	9.27	9.83
Earnings From Cont. Operations, 3 Yr. CAGR %	6.9	5.31	7.31	15.27	17.5
Net Income, 3 Yr. CAGR %	7	5.49	7.08	15.12	17.38
Normalized Net Income, 3 Yr. CAGR %	8.84	6.61	8.1	13.86	13.5
Diluted EPS Before Extra, 3 Yr. CAGR %	6.97	5.44	7.06	15.87	17.38
Accounts Receivable, 3 Yr. CAGR %	-1.21	0.96	-0.92	7.46	18.52
Inventory, 3 Yr. CAGR %	1.77	6.91	10.12	15.23	19.08
Net Property, Plant and Equip., 3 Yr. CAGR %	7.21	6.54	-1.78	-0.91	12.9
Total Assets, 3 Yr. CAGR %	5.53	7.96	7.03	7.06	26.11
Tangible Book Value, 3 Yr. CAGR %	8.56	9.44	11.09	10.22	-17.08
Common Equity, 3 Yr. CAGR %	7.38	8.55	8.1	7.5	8.42
Cash From Operations, 3 Yr. CAGR %	36.54	4.3	-0.51	-3.26	20.62
Capital Expenditures, 3 Yr. CAGR %	-21.15	-13.98	-24.02	-2.13	35.81
Levered Free Cash Flow, 3 Yr. CAGR %	33.51	5.72	35.56	62.77	12.42
Unlevered Free Cash Flow, 3 Yr. CAGR %	33.89	5.77	35.06	62.59	14.04
Dividend Per Share, 3 Yr. CAGR %	7.72	5.73	6.74	14.83	16.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.35	6.96	4.87	2.83	11.84
Gross Profit, 5 Yr. CAGR %	6.46	7.19	5.62	4.16	10.44
EBITDA, 5 Yr. CAGR %	13.15	14.32	10.61	7.92	9.81
EBITA, 5 Yr. CAGR %	11.38	12.76	9.63	6.71	6.73
EBIT, 5 Yr. CAGR %	11.38	12.76	9.63	6.71	6.73
Earnings From Cont. Operations, 5 Yr. CAGR %	11.2	11.99	10.3	9.56	11.19
Net Income, 5 Yr. CAGR %	11.17	12.05	10.24	9.54	11.14
Normalized Net Income, 5 Yr. CAGR %	10.8	11.6	10.95	9.58	9.9
Diluted EPS Before Extra, 5 Yr. CAGR %	11.14	12	10.22	9.96	11.12
Accounts Receivable, 5 Yr. CAGR %	6.97	7.69	0.74	2.94	10.7
Inventory, 5 Yr. CAGR %	7.37	9.34	7.59	9.42	14.47
Net Property, Plant and Equip., 5 Yr. CAGR %	4.45	4.42	3.11	3.25	7.65
Total Assets, 5 Yr. CAGR %	7.64	8.91	6.56	6.71	18.61
Tangible Book Value, 5 Yr. CAGR %	4.46	5.6	9.76	9.66	-7.02
Common Equity, 5 Yr. CAGR %	6.37	7.41	7.46	7.6	8.9
Cash From Operations, 5 Yr. CAGR %	14.86	12.42	14.6	3.96	13.49
Capital Expenditures, 5 Yr. CAGR %	-2.1	-5.48	-19.62	-10.51	10.79
Levered Free Cash Flow, 5 Yr. CAGR %	3.55	25.11	33.4	26.82	25.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.65	25.18	33.42	26.82	26.33
Dividend Per Share, 5 Yr. CAGR %	10.76	12.13	9.95	9.94	10.52